#HSBC on #GlenmarkPharma
Upgrade to Buy, TP Rs 1100
3Q disrupted qtr on back of restructuring of distribution model for its India formulations biz
Recovery in India sales, lower R&D spend, & start of supplies from Monroe plant bode well for margin expansion
